Michael Sinkoff, DO
Geriatric Medicine · Voorhees, NJNPI 1720227002
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $948, more than ten times the $56 reported in 2021.
Across 91 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$178
- AstraZeneca$164
- Novo Nordisk$160
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$143
- Otsuka America Pharmaceutical, Inc.$105
- Pfizer$98
- plus $823 from 24 others
What the payments were for
- Food & beverage$1,672100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 4 | $178 |
| AstraZeneca | 10 | $164 |
| Novo Nordisk | 11 | $160 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Pfizer | 6 | $98 |
| Abbott | 4 | $79 |
| Lilly USA, LLC | 5 | $79 |
| Amgen | 5 | $79 |
| Exact Sciences | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Lundbeck LLC | 3 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Corium, LLC | 3 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| GSK | 2 | $28 |
| UCB, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Vertex | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Medtronic | 1 | $15 |
| AbbVie | 1 | $14 |
| Merck | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$124
How this compares
$1,672 in reported general payments places this provider in the 75th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 257 | $111,111 |
| XareltoRivaroxaban | 135 | $50,123 |
| ProcritEpoetin Alfa | 14 | $29,230 |
| RexultiBrexpiprazole | 24 | $16,988 |
| TrulicityDulaglutide | 16 | $16,285 |
| JardianceEmpagliflozin | 22 | $14,021 |
| SantylCollagenase Clostridium Hist. | 15 | $9,640 |
| JanuviaSitagliptin Phosphate | 26 | $8,607 |
| Atorvastatin Calcium | 389 | $7,572 |
| EntrestoSacubitril/Valsartan | 11 | $4,353 |
| Metoprolol Succinate | 180 | $3,970 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 13 | $3,924 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $3,747 |
| Gabapentin | 151 | $3,635 |
| Divalproex Sodium | 98 | $3,416 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $98 | $115,035270 claims |
| Johnson & JohnsonXarelto, Procrit | $16 | $79,353149 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $105 | $16,98824 claims |
| Lilly USA, LLCTrulicity | $79 | $16,28516 claims |
| Boehringer IngelheimJardiance | $15 | $14,02122 claims |
| MerckJanuvia | $13 | $8,60726 claims |
| AstraZenecaBrilinta | $164 | $2,22413 claims |
| Sanofi-aventis U.S. LLCLantus | $40 | $2,06428 claims |
| Novo NordiskNovolog | $160 | $1,83023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Voorhees
- Mohammad HashmiVoorhees$2K
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.